PharmaEngine
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11f No. 10 Sec. 3 Minsheng E. Rd, Taipei...Website
www.pharmaengine.comRevenue
$17.3 MillionIndustry
About PharmaEngine
智擎生技 specializes in cancer treatment, focusing on the development of nanotechnology-based anticancer drugs. Their flagship product, ONIVYDE, is a liposomal formulation of camptothecin used for treating pancreatic cancer patients who have failed standard gemcitabine therapy, and it is available in over 40 countries including Taiwan, the USA, and Europe. Additionally, they are developing a new drug project, PEP07, a CHK1 inhibitor currently in Phase I clinical trials. The company aims to provide precise cancer therapies targeting DNA damage response and synthetic lethality.Explore more
PharmaEngine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
PharmaEngine Tech Stack
A closer look at the technologies used by PharmaEngine
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PharmaEngine
Sign Up For FreeTo access detailed company insights
智擎生技 specializes in cancer treatment, focusing on the development of nanotechnology-based anticancer drugs. Their flagship product, ONIVYDE, is a liposomal formulation of camptothecin used for treating pancreatic cancer patients who have failed standard gemcitabine therapy, and it is available in over 40 countries including Taiwan, the USA, and Eur... Read More
